Noushin Fahimfar|Davood Khalili|Sadaf G Sepanlou|Reza Malekzadeh|Fereidoun Azizi|Mohammad Alì Mansournia|Hamidreza Roohafza|Mohammad Hassan Emamian|Farzad Hadaegh|Hossein Poustchi|Marjan Mansourian|Hassan Hashemi|Maryam Sharafkhah|Akram Pourshams|Farshad Farzadfar|Ewout W. Steyerberg|Akbar Fotouhi
Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium
Tehran University of Medical Sciences|Research Institute for Endocrine Sciences|Shahid Beheshti University of Medical Sciences|National Student Clearinghouse Research Center|Tehran University of Medical Sciences|Tehran University of Medical Sciences|Research Institute for Endocrine Sciences|Shahid Beheshti University of Medical Sciences|National Student Clearinghouse Research Center|Tehran University of Medical Sciences|Cardiovascular Research Center|Isfahan University of Medical Sciences|Cardiovascular Institute Hospital|Ophthalmic Research Institute of Australia|Shahroud University of Medical Sciences|Shahid Beheshti University of Medical Sciences|National Student Clearinghouse Research Center|Research Institute for Endocrine Sciences|Tehran University of Medical Sciences|Cardiovascular Research Center|Isfahan University of Medical Sciences|Cardiovascular Institute Hospital|Noor Eye Hospital|Tehran University of Medical Sciences|Tehran University of Medical Sciences|Center for Non-Communicable Diseases|Tehran University of Medical Sciences|Erasmus MC|Tehran University of Medical Sciences
cardiovascular mortality western asia high still rising however data documented risk prediction derived western countries populationbased cohort studies conducted region current study aimed present process pooling data cardiovascular disease cvd mortality incidences four iranian cohortsfrom iran cohort consortium golestan cohort study gcs tehran lipid glucose study isfahan cohort study ics shahroud eye cohort study shecs eligible current study since appropriate data followup visits agestandardised cvd mortality rates estimated ages 4080 4065 years cox regression used compare mortalities among cohorts adjusted marginal rates calculated using poisson regressionoverall 61 291 participants 34 880 women aged 4080 years free cvd baseline included 504 606 personyears followup 1981 cvd deaths 885 women occurred agestandardisedsexstandardised premature cvd mortality rates estimated 133 per 100 000 personyears 95 ci 81 184 shecs 366 95 ci 342 389 gcs compared urban women rural women higher cvd mortality gcs ics gcs population higher risk cvd mortality compared others adjusted conventional cvd risk factorsthe incidence cvd mortality high differences urban rural cohorts iran western asian country pooling data facilitates opportunity globally evaluate risk prediction models